Search

everythinglearnresearchcommunity

for

Search:↓

Clotrimazole, an antifungal cream, may safely reduce skin pigmentation by breaking down the enzyme needed for making melanin.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Antizyme slows skin tumor growth by reducing cell growth in mice.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

Methylprednisolone treatment helps most alopecia areata patients, but young age, extensive hair loss, and low vitamin D can affect results.

Cyclosporine can cause a unique skin condition called "cyclosporine-induced folliculodystrophy."

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

Apremilast did not work for treating severe alopecia areata.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

A woman developed lupus after taking hydroxyurea for two years.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.

Abrocitinib may effectively treat stubborn alopecia universalis.

Early diagnosis and treatment of myositis in SLE patients lead to positive outcomes.